Insider · CIK 0001816676
Kanya Rajangam
Files at SNTI (Senti Biosciences, Inc.). First filing -, latest -.
Kanya Rajangam files SEC Form 4 as officer at SNTI (Senti Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kanya Rajangam has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | SNTI Senti Biosciences, Inc. | FTax withholding Common Stock | -10,757 | $0.00 | $0 | 74,843 | Mar 11, 2026 |
| Feb 2, 2026 | SNTI Senti Biosciences, Inc. | FTax withholding Common Stock | -1,384 | $0.00 | $0 | 85,600 | Feb 3, 2026 |
| Dec 9, 2024 | SNTI Senti Biosciences, Inc. | AGrant or award Series A Convertible Preferred Stockderivativeindirect: Iyer Family Revocable Trust dated Aug 26 2012 | +33 | $2,250.00 | $74k | 33 | Dec 10, 2024 |
| Dec 9, 2024 | SNTI Senti Biosciences, Inc. | AGrant or award Common Stock Warrant (right to buy)derivativeindirect: Iyer Family Revocable Trust dated Aug 26 2012 | +49,500 | $0.00 | $0 | 49,500 | Dec 10, 2024 |
Questions about Kanya Rajangam
Answered from the filings on this page, as of the latest one.
Is Kanya Rajangam buying or selling?
Kanya Rajangam has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kanya Rajangam's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kanya Rajangam has 0.
Where does Kanya Rajangam file Form 4?
Kanya Rajangam has filed Form 4 at SNTI (Senti Biosciences, Inc.) as Pres. & Chief Med. & Dev. Off.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.